132 related articles for article (PubMed ID: 19254220)
1. [Effect of carvedilol on parameters of myocardial perfusion in patients with left ventricular remodeling after myocardial infarction].
Kardiologiia; 2009; 49(2):66. PubMed ID: 19254220
[No Abstract] [Full Text] [Related]
2. Cardiac remodeling in coronary artery disease.
Sharpe N
Am J Cardiol; 2004 May; 93(9A):17B-20B. PubMed ID: 15144932
[TBL] [Abstract][Full Text] [Related]
3. [Comparative effects of carvediol in large, middle, and small dose in preventing left ventricular remodeling after acute myocardial infarction in rats].
Yang Y; Tang Y; Zhang P
Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(15):927-30. PubMed ID: 11702669
[TBL] [Abstract][Full Text] [Related]
4. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy.
Doughty RN; Whalley GA; Walsh HA; Gamble GD; López-Sendón J; Sharpe N;
Circulation; 2004 Jan; 109(2):201-6. PubMed ID: 14707020
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of cilazapril, carvedilol and their combination in preventing from left ventricular remodelling after acute myocardial infarction in rats.
Yang Y; Tang Y; Ruan Y; Li Y; Zhou Y; Gao R; Chen J; Chen Z
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):31-5. PubMed ID: 11984745
[TBL] [Abstract][Full Text] [Related]
6. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.
Dargie HJ
Lancet; 2001 May; 357(9266):1385-90. PubMed ID: 11356434
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction.
Senior R; Basu S; Kinsey C; Schaeffer S; Lahiri A
Am Heart J; 1999 Apr; 137(4 Pt 1):646-52. PubMed ID: 10097224
[TBL] [Abstract][Full Text] [Related]
8. [Effects of long-term therapy with angiotensin-converting enzyme inhibitor and carvedilol on the heart remodeling process after non-Q-wave myocardial infarction].
Bakaev RG; Strutynskiĭ AV; Kallaeva AN; Glazunov AB; Voronina MA; Pekhtereva DA; Moshkova NK; Chudnovskaia EA; Kochetkov BM
Klin Med (Mosk); 2011; 89(1):23-6. PubMed ID: 21516760
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol.
Crysant SG
Arch Fam Med; 1999; 8(4):295. PubMed ID: 10418532
[No Abstract] [Full Text] [Related]
10. [Comparative effects of carvedilol, losartan and their combination in preventing left ventricular remodeling after acute myocardial infarction in rats].
Yang Y; Tang Y; Ruan Y; Li Y; Gao R; Chen Z
Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):811-4. PubMed ID: 16206669
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics of medical use of Korvazan® for restorative treatment of patients with myocardial infarction, counting the risk factors].
Vakaliuk IP; Tymochko NB
Lik Sprava; 2013 Dec; (8):94-9. PubMed ID: 25726684
[TBL] [Abstract][Full Text] [Related]
12. Mitral regurgitation: has another magic bullet bitten the dust?
Borer JS
Circ Heart Fail; 2013 Jul; 6(4):624-6. PubMed ID: 23861504
[No Abstract] [Full Text] [Related]
13. The effects of different beta-blockers on left-ventricular volume and function after primary coronary stenting in acute myocardial infarction.
Lee SH; Yoon SB; Cho JR; Choi S; Jung JH; Lee N
Angiology; 2008 Dec-2009 Jan; 59(6):676-81. PubMed ID: 18388053
[TBL] [Abstract][Full Text] [Related]
14. Effects of early, late, and long-term nonselective β-blockade on left ventricular remodeling, function, and survival in chronic organic mitral regurgitation.
Pu M; Gao Z; Pu DK; Davidson WR
Circ Heart Fail; 2013 Jul; 6(4):756-62. PubMed ID: 23580745
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
[TBL] [Abstract][Full Text] [Related]
16. Myocardial dysfunction: hibernation and remodelling.
Köszegi Z; Balogh E
Lancet; 2003 Oct; 362(9393):1416-7; author reply 1417. PubMed ID: 14585649
[No Abstract] [Full Text] [Related]
17. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol: use in chronic heart failure.
Doughty RN; White HD
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
[TBL] [Abstract][Full Text] [Related]
19. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
20. Effects of carvedilol upon intra- and interventricular synchrony in patients with chronic heart failure.
Castro PF; Mc-Nab P; Quintana JC; Bittner A; Greig D; Vergara I; Vukasovic JL; Corbalan R; Copaja M; Díaz-Araya G; Chiong M; Troncoso R; Alcaino H; Lavandero S
Am J Cardiol; 2005 Jul; 96(2):267-9. PubMed ID: 16018855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
